A Study to Determine the Number of Participants With Rheumatoid Arthritis (RA) Who Meet the Requirements for Treatment With Anti-Tumor Necrosis Factor α (TNFα) in a General Hospital Setting in Korea

Prospective Cohort Study on Refractory Rheumatoid Arthritis

NCT07126431 ·Status: RECRUITING

Therapeutic Strategy in Patients Treated With Methotrexate for Rheumatoid Arthritis

NCT02288520 ·Status: COMPLETED

Rheumatoid Arthritis Satisfaction Outcome Research

NCT03703817 ·Status: COMPLETED

Effect of SAR153191 (REGN88) With Methotrexate in Patients With Active Rheumatoid Arthritis Who Failed TNF-α Blockers

NCT01217814 ·Status: TERMINATED ·Phase: PHASE2

Comparative Effectiveness of Targeted Therapy in RA Patients

NCT04449224 ·Status: UNKNOWN

An Open-label Study of GC012F in Rheumatoid Arthritis.

NCT07315503 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1

An Observational Study of MabThera/Rituxan (Rituximab) and Alternative TNF-Inhibitors in Patients With Rheumatoid Arthritis and an Inadequate Response to a Single Previous TNF-Inhibitor

NCT01557348 ·Status: COMPLETED

Adalimumab Administered in Korean Rheumatoid Arthritis Subjects Treated With Methotrexate

NCT00235859 ·Status: COMPLETED ·Phase: PHASE3

A Phase 2 Study to Evaluate the Safety, Tolerability, and Activity of Fontolizumab in Subjects With Active Rheumatoid Arthritis

NCT00281294 ·Status: TERMINATED ·Phase: PHASE2

Leflunomide + Methotrexate in Rheumatoid Arthritis

NCT00563849 ·Status: COMPLETED ·Phase: PHASE4

A Placebo-Controlled, Double-Blinded, Randomized Trial of Remicade in Korean Patients With Rheumatoid Arthritis Despite Methotrexate (Study P04280)(COMPLETED)

NCT00202852 ·Status: COMPLETED ·Phase: PHASE3

Study Looking at Longitudinal Changes in Fatigue and Health Status in Rheumatoid Arthritis (RA) Patients Treated With Subcutaneous Anti-TNF-α Therapy

NCT01521884 ·Status: COMPLETED

A Study of Filgotinib in Korean Participants With Rheumatoid Arthritis

NCT06625242 ·Status: COMPLETED ·Phase: PHASE4

An Observational Study in Rheumatoid Arthritis Patients Treated With RoActemra/Actemra (Tocilizumab)

NCT01565122 ·Status: COMPLETED

Efficacy of NNC109-0012 in Subjects With Active Rheumatoid Arthritis

NCT01282255 ·Status: COMPLETED ·Phase: PHASE2

Comparative Study of Janus Kinase (JAK) Inhibitors Vs Tumor Necrosis Factor (TNF) Inhibitors in Rheumatoid Arthritis

NCT05567380 ·Status: UNKNOWN

Treatment of TNFa Naive Patients With Poor Prognosis Rheumatoid Arthritis

NCT00963703 ·Status: COMPLETED ·Phase: NA

Observation of Treatment With Certolizumab Pegol in Daily Practice

NCT01069419 ·Status: COMPLETED

An Observational Quality of Life Study in Participants With Rheumatoid Arthritis Treated With Rituximab

NCT02507752 ·Status: COMPLETED

A Study to Evaluate the Long-Term Safety and Efficacy of GDC-0853 in Participants With Moderate to Severe Rheumatoid Arthritis Enrolled in Study GA29350

NCT02983227 ·Status: COMPLETED ·Phase: PHASE2

An Global Comparative Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis

NCT01543503 ·Status: COMPLETED

A Study of RoActemra/Actemra (Tocilizumab) in Combination With DMARDs Versus Current Best Practice DMARD Therapy in Patients With Rheumatoid Arthritis

NCT01251120 ·Status: TERMINATED ·Phase: PHASE4

A New Mode of Action of Anti-TNF, Reverse Signaling, in Rheumatoid Arthritis

NCT03216928 ·Status: COMPLETED ·Phase: NA

Study of the Functional Status Neutrophils in Rheumatoid Arthritis Patients to Identify New Biomarkers of Response to Anti-TNFalpha Therapy

NCT05802719 ·Status: RECRUITING ·Phase: NA

Safety and Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy of Repeat Doses of GSK2982772 in Subjects With Moderate to Severe Rheumatoid Arthritis (RA)

NCT02858492 ·Status: COMPLETED ·Phase: PHASE2